Alex John Shortt

Alex John Shortt

Auto-generated profile, based on publicly available information

Alex John Shortt

Moorfields Eye Hospital, London, UK

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2018 in Progress in Retinal and Eye Research
Verified
Journal Article
Closed access
HDHarminder Singh Dua
Harminder Singh Dua
DSDalia G. Said
Dalia G. Said
EMElisabeth M. Messmer
Elisabeth M. Messmer
MRMaurizio Rolando
Maurizio Rolando
JCJose Manuel Benitze del Castillo
Jose Manuel Benitze del Castillo
CBChristophe Baudouin
Christophe Baudouin

1 September 2007 in Survey of Ophthalmology
Verified
Journal Article
Closed access
ASAlex J. Shortt
Alex J. Shortt
GSGenevieve A. Secker
Genevieve A. Secker
MNMaria D. Notara
Maria D. Notara
GLG. Astrid Limb
G. Astrid Limb
PKPeng T. Khaw
Peng T. Khaw
JDJulie T. Daniels
Julie T. Daniels

1 March 2007 in Stem Cells
Verified
Journal Article
Closed access
PDF file
ASAlex J. Shortt
Alex J. Shortt
GSGenevieve A. Secker
Genevieve A. Secker
PMPeter M. Munro
Peter M. Munro
PKPeng T. Khaw
Peng T. Khaw
STStephen J. Tuft
Stephen J. Tuft
JDJulie T. Daniels
Julie T. Daniels
It is anticipated that stem cell (SC) therapy will enable the regeneration of diseased tissues and organs. Understanding SC niches is an essential step toward realizing this goal. By virtue of its optical transparency and physical separation of SC and transient amplifying cell compartments, the human cornea provides a unique opportunity to visualize and observe a population of adult stem cells, limbal epithelial stem cells (LESCs), in their niche environment. To date, the characteristics of the LESC niche have remained unclear. State-of-the-art imaging techniques were used to construct a three-dimensional (3D) view of the entire human corneal limbus and identify the structural characteristics of the LESC niche. Two distinct candidate LESC niche structures were identified. Cells within these structures express high levels of the putative limbal stem cell markers p63α and ABCG2; however, current methods cannot identify for certain which exact cells within this cell population are truly LESCs. These structures could be located and observed in vivo in normal human subjects, but not in patients with clinically diagnosed corneal LESC deficiency. The distribution of these structures around the corneal circumference is not uniform. Biopsies targeted to limbal regions rich in LESC niche structures yielded significantly higher numbers of LESCs in culture. Our findings demonstrate how adult stem cell niches can be identified and observed in vivo in humans and provide new biological insight into the importance of LESC niche structures in maintaining normal LESC function. Finally, the concept of targeted biopsy of adult SC niches improves stem cell yield and may prove to be essential for the successful development of novel adult stem cell therapies. Disclosure of potential conflicts of interest is found at the end of this article.

1 November 2008 in Ophthalmology
Verified
Journal Article
Closed access
ASAlex J. Shortt
Alex J. Shortt
GSGenevieve A. Secker
Genevieve A. Secker
MRMadhavan S. Rajan
Madhavan S. Rajan
GMGeorge Meligonis
George Meligonis
JDJohn K. Dart
John K. Dart
JDJulie T. Daniels
Julie T. Daniels

1 February 2009 in Biomaterials
Verified
Journal Article
Closed access
ASAlex J. Shortt
Alex J. Shortt
GSGenevieve A. Secker
Genevieve A. Secker
RLRichard J. Lomas
Richard J. Lomas
SWStacy P. Wilshaw
Stacy P. Wilshaw
JKJohn N. Kearney
John N. Kearney
JDJulie T. Daniels
Julie T. Daniels

17 January 2014 in Stem Cells Translational Medicine
Verified
Journal Article
Open access
PDF file
ASAlex J. Shortt
Alex J. Shortt
CBCatey Bunce
Catey Bunce
HHannah Levis
Hannah Levis
PBPeter Blows
Peter Blows
CDCaroline J. Doré
Caroline J. Doré
JDJulie T. Daniels
Julie T. Daniels
Limbal stem cell deficiency (LSCD) is an eye disorder in which the stem cells responsible for forming the surface skin of the cornea are destroyed by disease. This results in pain, loss of vision, and a cosmetically unpleasant appearance. Many new treatments, including stem cell therapies, are emerging for the treatment of this condition, but assessment of these new technologies is severely hampered by the lack of biomarkers for this disease or validated tools for assessing its severity. The aims of this study were to design and test the reliability of a tool for grading LSCD, to define a set of core outcome measures for use in evaluating treatments for this condition, and to demonstrate their utility. This was achieved by using our defined outcome set (which included the Clinical Outcome Assessment in Surgical Trials of Limbal stem cell deficiency [COASTL] tool) to evaluate the 3-year outcomes for allogeneic ex vivo cultivated limbal epithelial transplantation (allo-CLET) in patients who had bilateral total LSCD secondary to aniridia or Stevens-Johnson syndrome. The results demonstrate that our new grading tool for LSCD, the COASTL tool, is reliable and repeatable, and that improvements in the biomarkers used in this tool correlate positively with improvements in visual acuity. The COASTL tool showed that following allo-CLET there was a decrease in LSCD severity and an increase in visual acuity up to 12 months post-treatment, but thereafter LSCD severity and visual acuity progressively deteriorated.